foto

Drs. D.F. van Wijk

Position
PhD student
Main activities
Research
Specialisation
Vascular medicine
Focus of research

Novel anti-atherogenic strategies targeting the vessel wall
 

Key publications
  • Stroes ESG, van Wijk DF, Dalcetrapib: turning the tide for CETP inhibition?. LANCET 2011;378 (9802):1529-1530 [PubMed]
  • den Ruijter HM, Franssen R, Verkerk AO, van Wijk DF, Vaessen SF, Holleboom AG, Levels JH, Opthof T, Sungnoon R, Stroes ES, Kuivenhoven JA, Coronel R, Reconstituted High-Density Lipoprotein Shortens Cardiac Repolarization. J AM COLL CARDIOL 2011;58 (1):40-44 [PubMed]
  • van Wijk DF, van Leuven SI, Sandhu MS, Tanck MW, Hutten BA, Wareham NJ, Kastelein JJP, Stroes ESG, Khaw KT, Boekholdt SM, Chemokine Ligand 2 Genetic Variants, Serum Monocyte Chemoattractant Protein-1 Levels, and the Risk of Coronary Artery Disease. ARTERIOSCL THROM VAS 2010;30 (7):1460-U466 [PubMed]
  • van Leuven SI, van Wijk DF, Volger OL, de Vries JPPM, van der Loos CM, de Kleijn DVP, Horrevoets AJG, Tak PP, van der Wal AC, de Boer OJ, Pasterkamp G, Hayden MR, Kastelein JJP, Stroes ES, Mycophenolate mofetil attenuates plaque inflammation in patients with symptomatic carotid artery stenosis. ATHEROSCLEROSIS 2010;211 (1):231-236 [PubMed]
  • van Wijk DF, Stroes ESG, Dallinga-Thie GM, Novel insights into anti-inflammatory actions of HDL. ATHEROSCLEROSIS 2010;212 (2):388-389 [PubMed]
All Publications